Eliminating Risk of Preventable Adverse Drug Events at the Hospital-community Interface of Care

NCT ID: NCT01164137

Last Updated: 2013-02-15

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 156 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2008-11-30
• Study Completion Date: 2013-02-28

Brief Summary

This initiative aims to decrease the risk of medication errors at the hospital-community interface as well as health system utilization following hospital discharge by implementing a pharmacist-led medication reconciliation in the patients' home within 72 hours of hospital discharge.

Detailed Description

The goals of this initiative are to decrease the risk for medication errors at the hospital community interface of care, thus decreasing preventable adverse drug events and preventable drug-related health system utilization following hospital discharge. This initiative has four objectives that aim to:

1. Develop and test a community-based medication reconciliation process/intervention.

2. Design and conduct a randomized controlled trial to examine the impact of the intervention on post-discharge health services utilization by comparing a set of outcome variables between intervention and non-intervention groups.

3. Design a risk prediction model that helps identify patients discharged from in-patient care with the highest level of need for the intervention.

4. Determine whether a community-based medication reconciliation process/intervention adds risk reduction value to individuals who have undergone an in-hospital medication reconciliation.

Conditions

Adverse Drug Events

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: HEALTH_SERVICES_RESEARCH
• Blinding Strategy: NONE

Study Groups

Medication Reconciliation Intervention

Participants receiving a pharmacist-led home intervention conducted within 72 hours of hospital discharge aimed at identifying and correcting medication discrepancies.

Group Type: EXPERIMENTAL

Medication Reconciliation

Intervention Type: BEHAVIORAL

A pharmacist-led home intervention conducted within 72 hours of hospital discharge aimed at correcting and identifying medication discrepancies.

Medication Reconciliation Non-Interven.

Participants not receiving a pharmacist-led home intervention conducted within 72 hours of hospital discharge aimed at identifying and correcting medication discrepancies.

Group Type: NO_INTERVENTION

No interventions assigned to this group

Interventions

Medication Reconciliation

A pharmacist-led home intervention conducted within 72 hours of hospital discharge aimed at correcting and identifying medication discrepancies.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• Patients attending the WestView Health Centre Medicine/Family Health Unit with at least one medication at discharge.

Exclusion Criteria

• First Nations persons
• Residents of continuing care or assisted living facilities
• Persons not residing in the Edmonton, AB, Canada region
• Persons who obtain a score of 19 or less on the Mini Mental State Examination (MMSE)

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Westview Physician Collaborative

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Allan Bailey, M.D.

Role: PRINCIPAL_INVESTIGATOR

Westview Physician Collaborative

Grace Moe, M.Sc.P.T.

Role: STUDY_DIRECTOR

WestView Primary Care Network

Locations

WestView Health Centre

Stony Plain, Alberta, Canada

Countries

Canada

Other Identifiers

CMPA#2026

Identifier Type: -

Identifier Source: org_study_id